Abdominal in Biological Technology

AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women

... associated with constipation, the presence of abdominal discomfort or pain is what differentiates IBS-C ... nausea (29%), diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distention (6%), and ... > 4%) were nausea (8%), diarrhea (7%), and abdominal pain (5%). Please see complete Prescribing ...

C1-Esterase Inhibitor Concentrate Rapidly Relieves Abdominal and Facial Attacks in Patients with Hereditary Angioedema, According to Pivotal Study

... the abdomen, and/or the larynx. Patients who have abdominal attacks can experience episodes of severe pain, ... placebo in HAE patients who experience facial and abdominal attacks," said Jonathan A. Bernstein, MD, ... attacks can occur all over the body, facial and abdominal swelling can be the most painful ...

Recent Study Confirms Alimentary Health's Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome

... upsets, including constipation, diarrhea, abdominal discomfort, urgency, gas and bloating. Bifantis ... digestive upsets such as constipation, diarrhea, abdominal discomfort, urgency, gas, and ... to placebo for the primary outcome measure abdominal pain/discomfort as well as the secondary measures ...

FDA Accepts Sucampo's sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

... one-third of these cases. IBS-C symptoms include abdominal pain and discomfort associated with defecation or ... diarrhea (6% vs. 4%, respectively) and abdominal pain (4% vs. 5%, respectively). About Irritable ... diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distension (6%) and ...

The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio

... (IPHC) to treat metastastic abdominal cancers regardless of primary site, especially ... hyperthermic treatment for disseminated abdominal cancer, therefore, represents a ... of ovarian, colon, rectal and additional abdominal cancers creates potential for the TTS product to ...

Signostics Receives FDA Clearance for World's Smallest Ultrasound Product

... images anywhere, at any time for general medical applications, including: abdominal assessments such as bladder, abdominal aortic aneurysm screening, and trauma assessment; musculoskeletal; and ...

Evoke Pharma, Inc. Initiates Phase 2b Metoclopramide Intranasal Trial (MINT) in Patients With Diabetic Gastroparesis

... cause of gastroparesis, but other identified causes include previous abdominal surgery, neurologic conditions, and infection. Symptoms associated with ... particularly vomiting of food ingested several hours previously, upper abdominal distention (bloating), early satiety, and anorexia. Severe symptoms may ...

Tepha Partner Launches Novel Monofilament Absorbable Suture Utilizing Tepha's Proprietary Biomaterial

... Study to Evaluate the Safety and Efficacy of Aesculap MonoMax for abdominal Wall Closure or (ISSAAC), was recently concluded with positive results. ... suture was used for a continuous all-layer (except skin) suture to close abdominal wall after midline incisions. The primary objective of the trial was to ...

Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis

... lining, which may lead to bloody stools, severe diarrhea and frequent abdominal pain. Tiny open sores, or ulcers, form on the surface of the lining where ... predisposition. Symptoms of Crohn's disease can vary but often include abdominal pain and tenderness, persistent diarrhea, rectal bleeding, weight loss and ...

Helping Young Women Succeed in Today's Unpredictable World

... sexually transmitted diseases (STDs). Side effects may include nausea, abdominal pain, fatigue, headache, changes in your period, dizziness, and breast ... period is more than a week late, you may be pregnant. If you have severe abdominal pain, you may have an ectopic pregnancy and should get immediate medical ...

Naglazyme Approved by Brazil's National Health Surveillance Agency

... were headache, fever, arthralgia, vomiting, upper respiratory infections, abdominal pain, diarrhea, ear pain, cough, and otitis media. Severe reactions ... urticaria. Nausea, vomiting, elevated blood pressure, retrosternal pain, abdominal pain, malaise, and joint pain were also reported. No patients discontinued ...

Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval

... XL, a newly FDA-approved, minimally invasive device for the treatment of abdominal aortic aneurysms (AAA). The procedure was performed at Arizona Heart ... an aortic neck diameter of 30 mm. AAA is a weakening in the wall of the abdominal aorta which results in a balloon-like enlargement. About 1.7 million ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

... greater than or equal to 50%) were fatigue (89%), rash/desquamation (89%), abdominal pain (59%), and pain-other (51%). The most common grade 3/4 adverse events ... or equal to 10%) included: fatigue (33%), pain-other (16%), dyspnea (16%), abdominal pain (14%), infection without neutropenia (13%), rash/desquamation (12%), ...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

... or ascites; 3%; 8%) and superficial edema (6%; 5%), hemorrhage (6%; 11%), abdominal pain (11%; 4%), nausea (6%; 4%), diarrhea (3%; 7%) and musculoskeletal ... 74%), muscle cramps (47%; 58%), diarrhea (59%; 70%), fatigue (48%; 53%), abdominal pain (40%; 37%), rash and related terms (38%; 53%), vomiting (38%; 35%), ...

Aortic Stent Grafts Will Boost Canadian and Japanese Peripheral Vascular Markets

... thoracic stent graft to receive regulatory approval in Japan. The first abdominal stent grafts were approved in 2006. Procedures will experience robust ... or artery) directly above the iliac bifurcation is referred to as an abdominal aortic aneurysm (AAA); one located in the ascending aorta, aortic arch, or ...

Naglazyme Approved by Japanese Ministry of Health

... were headache, fever, arthralgia, vomiting, upper respiratory infections, abdominal pain, diarrhea, ear pain, cough, and otitis media. Severe reactions ... urticaria. Nausea, vomiting, elevated blood pressure, retrosternal pain, abdominal pain, malaise, and joint pain were also reported. No patients discontinued ...

Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management

... Other commonly reported side effects include indigestion, headache, pain, abdominal pain, nausea, itching, diarrhea, runny nose, vomiting and rash. More ... medications they are taking. The most common side effects are headache, abdominal pain, and constipation. About Abbott Abbott is a global, broad-based ...

AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test

... 6 million patients enter hospital emergency rooms (ERs) complaining of abdominal pain, and who could potentially have appendicitis. Upon entering the ER, ... rapidly help diagnose or rule out appendicitis in patients complaining of abdominal pain. For more information, please visit: http://www.aspenbiopharma.com ...

FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer

... stomatitis/mucositis 20% (Grade 3/4: 3%), alopecia 3% (Grade 3/4: 0%), abdominal pain 14% (Grade 3/4: 1%), nail disorder 10% (Grade 3/4: <1%), ... palmar-plantar erythrodysesthesia (hand-foot) syndrome, anorexia, abdominal pain, nail disorder, and constipation. Drug-associated hematologic ...

Cardica's C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries

... stapling and suturing devices made laparoscopic surgery commonplace for abdominal surgeries, the Flex A system overcomes the most significant limitation in ... in the chest area, similar to the procedures for minimally-invasive abdominal surgery. To ensure the highest level of safety for the patient, the ...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

... or equal to 10 percent) in the dose-optimization phase for patients taking Vyvanse were decreased appetite, insomnia, headache, irritability, upper abdominal pain, and affect lability. Vyvanse, which was introduced in the United States in July 2007 for the treatment of ADHD in children aged 6 to ...

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

... but decreases over time in most patients. If patients experience the following severe and persistent symptoms (alone or in combination): abdominal pain, nausea, vomiting, or diarrhea, they should talk to their healthcare provider because these symptoms could be signs of serious medical ...

Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome

... the gastrointestinal tract. These tumors secrete large amounts of serotonin, which can cause a variety of symptoms including severe diarrhea and abdominal discomfort. Patients with carcinoid syndrome currently have limited therapeutic options, and the standard of care includes chronic therapy with ...

Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial

... and reduced 28-day mortality in patients with severe sepsis and septic shock. The article entitled "Early Use of Polymyxin B Hemoperfusion in abdominal Septic Shock: The EUPHAS Randomized Controlled Trial," was published in the Journal of the American Medical Association (JAMA). Spectral has ...

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

... and twice placebo) in the dose optimization phase for patients taking VYVANSE were decreased appetite, insomnia, headache, irritability, upper abdominal pain, and affect lability (mood swings). VYVANSE, which was introduced in the United States in July 2007 for the treatment of ADHD in children ...

Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD

... worse, contact your health care provider. The most common side effects with ASMANEX in patients 4-11 years old include fever, allergic rhinitis, abdominal pain, vomiting, urinary tract infection, and bruise. The most common side effects with ASMANEX in patients 12 years of age and older include ...

Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting

... 20% related to Nexavar for both HCC and RCC were fatigue, weight loss, rash/desquamation, hand-foot skin reaction, alopecia, diarrhea, nausea, and abdominal pain. Grade 3/4 adverse events in HCC and RCC patients, respectively, were 45% for Nexavar vs. 32% for placebo and 38% for Nexavar and 28% for ...

The Crohn's & Colitis Foundation of America and Shire Launch Virtual 'IBD March on the Hill' to Increase Funding for Digestive Disease Research

... disease may attack anywhere from the mouth to the anus, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause ...

Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes

... but decreases over time in most patients. If patients experience the following severe and persistent symptoms (alone or in combination): abdominal pain, nausea, vomiting, or diarrhea, they should talk to their healthcare provider because these symptoms could be signs of serious medical ...

Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

... "A Phase III, Multi-Center, Randomized, Double-blind, Placebo-Controlled 24 Hour Study of the Efficacy and Safety of Intravenous Acetaminophen in abdominal Laparoscopic Surgery" (Study 304; abstract number 97) "A Phase III, Multicenter, Open-label, Prospective, Repeated Dose, Multi Day Randomized ...

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

... but decreases over time in most patients. If patients experience the following severe and persistent symptoms (alone or in combination): abdominal pain, nausea, vomiting, or diarrhea, they should talk to their healthcare provider because these symptoms could be signs of serious medical ...

Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome

... disorders diagnosed by physicians. At least twice as many women as men are affected by IBS, a disorder characterized most commonly by cramping, abdominal pain, bloating, constipation and diarrhea. Although it significantly impairs health-related quality of life, many people suffer from IBS for years ...

BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University

... series of biomarker discovery studies for heart disease and early detection of metabolic syndrome -- a combination of certain risk factors, including abdominal obesity, hypertension, and insulin resistance -- which are believed to increase the risk of developing cardiovascular disease and diabetes. BG ...

Surgeons Perform First Incisionless Bariatric Procedure in the United States

... "Eliminating skin incisions offers important advantages including reduced risk of infection, less post-operative pain, faster recovery time and no abdominal scars." The POSE procedure was performed on 51-year-old Teresia McArthur of Georgetown, who has been battling her weight for more than 15 ...

Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C

... liver failure. The disease is transmitted by contact with HCV-infected blood. A large majority of those infected do not show symptoms, but fatigue, abdominal pain and nausea can be common. The current standard treatment of care, peginterferon and ribavirin, is effective in about half of all patients ...

FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD

... preclude the presence of gastric malignancy. The most commonly reported treatment-emergent adverse reactions (greater than or equal to 2%): diarrhea, abdominal pain, nausea, upper respiratory tract infection, vomiting, and flatulence. KAPIDEX should not be co-administered with atazanavir. KAPIDEX may ...

Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009

... to simultaneously pass various surgical instruments, LESS may also reduce complications that might occur after traditional open and even laparoscopic abdominal surgery. My patients report less discomfort and have faster recoveries compared to those undergoing traditional laparoscopy." According to the ...

Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study

... of diabetic complications and represent an advanced stage of the disease. However, TZDs have been observed to have side effects of weight gain and abdominal obesity, which exacerbate the diabetic condition itself, and to cause edema and exacerbate congestive heart failure in certain patients. Individuals ...

SurgiQuest Signs a Development and Supply Agreement with Intuitive Surgical for MIS Access Utilizing the AirSeal(TM) Technology

... system presents a significant technological breakthrough in minimally invasive surgery (MIS). The AirSeal system provides unobstructed access to the abdominal cavity and dramatically reduces variations of intra-abdominal pressure due to its ability to completely eliminate seals and gaskets. SurgiQuest's ...

Introducing deCODEme Cardio(TM) and deCODEme Cancer(TM)

... be found on our blog, at www.deCODEyou.com . deCODEme Cardio(TM) measures 8 SNPs associated with the risk of heart attack, intracranical and abdominal aortic aneurysm, stroke and atrial fibrillation, peripheral arterial disease (PAD) and venous thromboempolism. deCODEme Cancer(TM) measures 29 SNPs ...